Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 384

Centre d'Etudes et de Recherches Internationales et Communautaires (CERIC)

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Non-profit Research Organisations
  • Academic Bodies

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation

Additional information

CERIC is a multidisciplinary research team comprising mainly lawyers in public and private law, specialists in domestic, comparative, international and European law

Centre for Future Affordable & Sustainable Therapy Development (FAST)

Region/Country:  
  • Countries in the EU/EEA
  • Netherlands

Type of Actor:

  • Networks
  • European and Regional Networks
  • Non-profit Research Organisations
  • National Research Centres

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research
  • Manufacturing
  • Commercialisation
  • Patient and Public Involvement

Additional information

FAST (Centre for Future Affordable & Sustainable Therapy Development) is an independent national centre of expertise and collaboration, devoted to driving innovation in therapy development.

Resources

Centre for Regenerative Medicine, University of Edinburgh (CRM)

Region/Country:  
  • UK

Type of Actor:

  • Non-profit Research Organisations
  • Academic Bodies

Development Stage:

  • Fundamental Research
  • Clinical Research

Conditions and Diseases:

  • Heart disease
  • Cancer
  • Parkinson's Disease
  • Multiple Sclerosis

Additional information

The Centre for Regenerative Medicine (CRM) is a research centre based at the University of Edinburgh's Institute for Regeneration and Repair. Our Scientists and clinicians study stem cells, disease and tissue repair to advance human health. Research at the Centre is aimed at developing new treatments for major diseases including cancer, heart disease, liver failure, and degenerative diseases such as multiple sclerosis and Parkinson's.

Centro Nacional de Certificación de Productos Sanitarios

Region/Country:  
  • Countries in the EU/EEA
  • Spain

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

CERTIQUALITY S.r.l.

Region/Country:  
  • Countries in the EU/EEA
  • Italy

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

Český metrologický institut (Czech metrology institute) (CMI)

Region/Country:  
  • Countries in the EU/EEA
  • Czechia

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

Comité de protection des personnes (CPP)

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Research
  • Ethics Committees
  • Research Ethics Committees

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Translational Research

Additional information

CPPs are research ethics committees. They issue opinions on the conditions for the validity of research involving humans, particularly in clinical trials. There are 39 of them throughout France.

Commission for Economic Evaluation and Public Health – French HAS (Commission d’évaluation économique et de santé publique – HAS) (CEESP)

Type of Actor:

  • Regulators
  • Payers

Development Stage:

  • Commercialisation

Additional information

The CEESP made up of experts chosen for their competence in the field of health, economic evaluation and public health, and members chosen from among the members of an association of patients and users of the healthcare system, is a specialised commission affiliated to the High Authority for Health (HAS). It is responsible for producing medico-economic opinions on healthcare procedures, products and services, determining the most efficient therapeutic strategies and issuing recommendations accordingly. These analyses and assessments are intended for healthcare products and technologies that are presumed to be innovative and likely to have a significant impact on health insurance expenditure. Taking into account the price claimed by the company, CEEPS assesses the efficiency and financial impact of the medicine on public expenditure, with a view to informing decisions on medicine pricing and not those relating to reimbursement.

Competent Authorities for Medical Devices Group (CAMD)

Region/Country:  
  • EU/EEA

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Medical Device Authorities
  • Supranational Medical Device Authorities

Development Stage:

  • Clinical Research
  • Manufacturing
  • Commercialisation

Conseils départementaux et régionaux (Departmental and regional councils)

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Research Funding Authorities
  • National Research Funding Authorities
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts